Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 44 Prostatic Neoplasms, Castration-Resistant 2 Neoplasm Metastasis 2 Stage II Prostate Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Prostate Cancer Metastatic Disease 1 Prostate Adenocarcinoma 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms 1 Neoadjuvant Therapy 1 Low Risk Prostate Cancer 1 High Risk Prostate Cancer 1 Hematologic Neoplasms 1 Castration Levels of Testosterone 1 Carcinoma, Small Cell 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Low Risk Prostate Cancer × apalutamide × Clear all

NCT03088124 2026-03-20

PC-ARN

Institut Paoli-Calmettes

Phase 2 Completed

Low Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡